The effect of inflammatory cytokines in alcoholic liver disease

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Kawaratani, Hideto ^a   Tsujimoto, Tatsuhiro ^a   Douhara, Akitoshi ^a   Takaya, Hiroaki ^a   Moriya, Kei ^a   Namisaki, Tadashi ^a   Noguchi, Ryuichi ^a   Yoshiji, Hitoshi ^a   Fujimoto, Masao ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHEMOKINE; CYTOKINE; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

ANIMALS; CHEMOKINES; CYTOKINES; ETHANOL; HUMANS; INFLAMMASOMES; INTERLEUKIN-10; INTERLEUKIN-6; LIVER DISEASES, ALCOHOLIC; OXIDATIVE STRESS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893863556     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/495156     Document Type: Review

References (113)

1. Browning J. D., Horton J. D., Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 2004 114 2 147 152 2-s2.0-4043077961 10.1172/JCI200422422 (Pubitemid 39071617)
2. MacSween R. N. M., Burt A. D., Histologic spectrum of alcoholic liver disease. Seminars in Liver Disease 1986 6 3 221 232 2-s2.0-0023025701 (Pubitemid 17203551)
3. Haber P. S., Warner R., Seth D., Gorrell M. D., McCaughan G. W., Pathogenesis and management of alcoholic hepatitis. Journal of Gastroenterology and Hepatology 2003 18 12 1332 1344 2-s2.0-0346729708 10.1046/j.1440-1746.2003. 03217.x (Pubitemid 38045845)
4. Tsujimoto T., Kuriyama S., Yamazaki M., Nakatani Y., Okuda H., Yoshiji H., Fukui H., Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. International Journal of Oncology 2001 18 1 41 47 2-s2.0-0035219825
5. Kitazawa T., Nakatani Y., Fujimoto M., Tamura N., Uemura M., Fukui H., The production of tumor necrosis factor- α by macrophages in rats with acute alcohol loading. Alcoholism 2003 27 8 72S 75S 2-s2.0-0042163140 (Pubitemid 36999205)
6. Iimuro Y., Gallucci R. M., Luster M., Kono H., Thurman R. G., Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997 26 6 1530 1537 2-s2.0-0030716183 (Pubitemid 27520019)
7. Rao R. K., Seth A., Sheth P., Recent advances in alcoholic liver disease. I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2004 286 6 G881 G884 2-s2.0-2642553874 10.1152/ajpgi.00006.2004 (Pubitemid 38715649)
8. Park P.-H., Thakur V., Pritchard M. T., McMullen M. R., Nagy L. E., Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin. Journal of Gastroenterology and Hepatology 2006 21 3 S30 S33 2-s2.0-33747605552 10.1111/j.1440-1746.2006.04580.x (Pubitemid 44266546)
9. Canbay A., Feldstein A. E., Higuchi H., Werneburg N., Grambihler A., Bronk S. F., Gores G. J., Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003 38 5 1188 1198 2-s2.0-0142151769 10.1053/jhep.2003.50472 (Pubitemid 37314827)
10. McClain C. J., Song Z., Barve S. S., Hill D. B., Deaciuc I., Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2004 287 3 G497 G502 2-s2.0-4143065802 10.1152/ajpgi.00171. 2004 (Pubitemid 39096613)
11. Tilg H., Diehl A. M., Cytokines in alcoholic and nonalcoholic steatohepatitis. The New England Journal of Medicine 2000 343 20 1467 1467 2-s2.0-0034676629 10.1056/NEJM200011163432007
12. Gao B., Cytokines, STATs and liver disease. Cellular & Molecular Immunology 2005 2 2 92 100 2-s2.0-32944463507
13. Garcin F., Lau You Hin G., Cote J., Aldehyde dehydrogenase in drosophila: developmental and functional aspects. Alcohol 1985 2 1 85 89 2-s2.0-0021952111 10.1016/0741-8329(85)90021-7 (Pubitemid 15119116)
14. Lieber C. S., DeCarli L. M., The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo. Journal of Pharmacology and Experimental Therapeutics 1972 181 2 279 287 2-s2.0-0015333453
15. Neve E. P. A., Ingelman-Sundberg M., Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. Journal of Biological Chemistry 2000 275 22 17130 17135 2-s2.0-0034595984 10.1074/jbc.M000957200 (Pubitemid 30398958)
16. Lieber C. S., Metabolic consequences of ethanol. The Endocrinologist 1994 4 2 127 139 2-s2.0-0028261915 (Pubitemid 24092473)
17. Bilzer M., Roggel F., Gerbes A. L., Role of Kupffer cells in host defense and liver disease. Liver International 2006 26 10 1175 1186 2-s2.0-33750999322 10.1111/j.1478-3231.2006.01342.x (Pubitemid 44741204)
18. Diehl A. M., Recent events in alcoholic liver disease: V. Effects of ethanol on liver regeneration. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2005 288 1 G1 G6 2-s2.0-10844265570 10.1152/ajpgi.00376.2004 (Pubitemid 39665213)
19. Hansen J., Cherwitz D. L., Allen J. I., The role of tumor necrosis factor- α in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 1994 20 2 461 474 2-s2.0-0027992143 10.1016/0270-9139(94)90200-3 (Pubitemid 24233375)
20. Aldred A., Nagy L. E., Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF- α production in rat Kupffer cells. The American Journal of Physiology: Gastrointestinal and Liver Physiology 1999 276 1 G98 G106 2-s2.0-0032917769 (Pubitemid 29063605)
21. Hill D. B., Marsano L., Cohen D., Allen J., Shedlofsky S., McClain C. J., Increased plasma interleukin-6 concentrations in alcoholic hepatitis. The Journal of Laboratory and Clinical Medicine 1992 119 5 547 552 2-s2.0-0026655214
22. Kawaratani H., Tsujimoto T., Kitazawa T., Kitade M., Yoshiji H., Uemura M., Fukui H., Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. World Journal of Gastroenterology 2008 14 43 6655 6661 2-s2.0-63449086438 10.3748/wjg.14.6655
23. Crespo J., Cayoen A., Fernendez-Gil P., Hernndez-Guerra M., Mayorga M., Domnguez-Dez A., Fernndez-Escalante J. C., Pons-Romero F., Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001 34 6 1158 1163 2-s2.0-0035183475 10.1053/jhep.2001.29628 (Pubitemid 33096588)
24. Matsuyama T., Uemura M., Ishikawa M., Matsumoto M., Ishizashi H., Kato S., Morioka C., Fujimoto M., Kojima H., Yoshiji H., Takimura C., Fujimura Y., Fukui H., Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcoholism 2007 31 1 S27 S35 2-s2.0-33846291847 10.1111/j.1530-0277.2006.00283.x (Pubitemid 46114912)
25. Ishikawa M., Uemura M., Matsuyama T., Matsumoto M., Ishizashi H., Kato S., Morioka C., Fujimoto M., Kojima H., Yoshiji H., Tsujimoto T., Takimura C., Fujimura Y., Fukui H., Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia. Alcoholism 2010 34 1 S25 S33 2-s2.0-74849121386 10.1111/j.1530-0277.2008.00850.x
26. Uemura M., Fujimura Y., Matsuyama T., Matsumoto M., Ishikawa M., Ishizashi H., Kato S., Tsujimoto T., Fujimoto M., Yoshiji H., Morioka C., Fukui H., Potential role of ADAMTS13 in the progression of alcoholic hepatitis. Current Drug Abuse Reviews 2008 1 2 188 196 2-s2.0-69249239123
27. Akriviadis E., Botla R., Briggs W., Han S., Reynolds T., Shakil O., Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 6 1637 1648 2-s2.0-0034465251 (Pubitemid 32198689)
28. Tilg H., Jalan R., Kaser A., Davies N. A., Offner F. A., Hodges S. J., Ludwiczek O., Shawcross D., Zoller H., Alisa A., Mookerjee R. P., Graziadei I., Datz C., Trauner M., Schuppan D., Obrist P., Vogel W., Williams R., Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. Journal of Hepatology 2003 38 4 419 425 2-s2.0-0037386110 10.1016/S0168- 8278(02)00442-7 (Pubitemid 36399243)
29. Kawaratani H., Tsujimoto T., Kitazawa T., Yoshiji H., Uemura M., Fukui H., Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model. Journal of Gastroenterology and Hepatology 2011 26 4 775 783 2-s2.0-79952856333 10.1111/j.1440-1746.2011.06658.x
30. Sheron N., Bird G., Goka J., Alexander G., Williams R., Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clinical and Experimental Immunology 1991 84 3 449 453 2-s2.0-0025845292
31. Hong F., Kim W.-H., Tian Z., Jaruga B., Ishac E., Shen X., Gao B., Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins. Oncogene 2002 21 1 32 43 2-s2.0-0037011992 10.1038/sj.onc.1205016 (Pubitemid 34076376)
32. Latvala J., Hietala J., Koivisto H., Järvi K., Anttila P., Niemelä O., Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. American Journal of Gastroenterology 2005 100 6 1303 1310 2-s2.0-21344457230 10.1111/j.1572-0241. 2005.41509.x (Pubitemid 40904353)
33. El-Assal O., Hong F., Kim W.-H., Radaeva S., Gao B., IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cellular & molecular immunology 2004 1 3 205 211 2-s2.0-12744259191
34. Zhang X., Tachibana S., Wang H., Hisada M., Williams G. M., Gao B., Sun Z., Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology 2010 52 6 2137 2147 2-s2.0-78649614542 10.1002/hep.23909
35. Rabe B., Chalaris A., May U., Waetzig G. H., Seegert D., Williams A. S., Jones S. A., Rose-John S., Scheller J., Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 2008 111 3 1021 1028 2-s2.0-38949164424 10.1182/blood-2007-07-102137 (Pubitemid 351213379)
36. Mathurin P., Deng Q.-G., Keshavarzian A., Choudhary S., Holmes E. W., Tsukamoto H., Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 2000 32 5 1008 1017 2-s2.0-0033765501
37. Hawrylowicz C. M., O'Garra A., Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nature Reviews Immunology 2005 5 4 271 283 2-s2.0-17144405680 10.1038/nri1589 (Pubitemid 40516153)
38. Louis H., Le Moine O., Goldman M., Devière J., Modulation of liver injury by interleukin-10. Acta Gastro-Enterologica Belgica 2003 66 1 7 14 2-s2.0-0037222997 (Pubitemid 36307052)
39. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 1991 146 10 3444 3451 2-s2.0-0025763807
40. De Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., De Vries J. E., Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine 1991 174 5 1209 1220 2-s2.0-0026094306
41. Hill D. B., D'Souza N. B., Lee E. Y., Burikhanov R., Deaciuc I. V., De Villiers W. J. S., A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcoholism 2002 26 1 74 82 2-s2.0-0036146801 (Pubitemid 34093514)
42. Miller A. M., Wang H., Bertola A., Park O., Horiguchi N., Hwan Ki S., Yin S., Lafdil F., Gao B., Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. Hepatology 2011 54 3 846 856 2-s2.0-80052005701 10.1002/hep.24517
43. Nanji A. A., Jokelainen K., Rahemtulla A., Miao L., Fogt F., Matsumoto H., Tahan S. R., Su G. L., Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999 30 4 934 943 2-s2.0-0032862559 10.1002/hep.510300402 (Pubitemid 29458282)
44. Jura J., Wegrzyn P., Korostyński M., Guzik K., Oczko-Wojciechowska M., Jarzab M., Kowalska M., Piechota M., Przewłocki R., Koj A., Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochimica et Biophysica Acta 2008 1779 6-7 383 389 2-s2.0-45349109007 10.1016/j.bbagrm.2008.04.006 (Pubitemid 351847863)
45. Acosta-Rodriguez E. V., Napolitani G., Lanzavecchia A., Sallusto F., Interleukins 1 β and 6 but not transforming growth factor- β are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology 2007 8 9 942 949 2-s2.0-34548125305 10.1038/ni1496 (Pubitemid 47300008)
46. Weaver C. T., Hatton R. D., Mangan P. R., Harrington L. E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual Review of Immunology 2007 25 821 852 2-s2.0-33847206969 10.1146/annurev.immunol.25. 022106.141557 (Pubitemid 46697925)
47. Lafdil F., Miller A. M., Ki S. H., Gao B., Th17 cells and their associated cytokines in liver diseases. Cellular and Molecular Immunology 2010 7 4 250 254 2-s2.0-77957274840 10.1038/cmi.2010.5
48. Lemmers A., Moreno C., Gustot T., Maréchal R., Degré D., Demetter P., de Nadai P., Geerts A., Quertinmont E., Vercruysse V., Le Moine O., Devière J., The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009 49 2 646 657 2-s2.0-61949356502 10.1002/hep.22680
49. Nanji A. A., Zhao S., Sadrzadeh S. M. H., Dannenberg A. J., Tahan S. R., Waxman D. J., Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcoholism 1994 18 5 1280 1285 2-s2.0-0027986662 10.1111/j.1530-0277.1994. tb00119.x (Pubitemid 24345545)
50. Ki S. H., Park O., Zheng M., Morales-Ibanez O., Kolls J. K., Bataller R., Gao B., Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010 52 4 1291 1300 2-s2.0-77957946415 10.1002/hep.23837
51. Dinarello C. A., Interleukin-1 β and the autoinflammatory diseases. The New England Journal of Medicine 2009 360 23 2467 2470 2-s2.0-66649122286 10.1056/NEJMe0811014
52. Petrasek J., Bala S., Csak T., IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. The Journal of Clinical Investigation 2012 122 3476 3489
53. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., Huber C., Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992 103 1 264 274 2-s2.0-0026691627
54. Mertens M., Singh J. A., Anakinra for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2009 1 CD005121 2-s2.0-62449279222
55. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
56. Gustot T., Lemmers A., Moreno C., Nagy N., Quertinmont E., Nicaise C., Franchimont D., Louis H., Devière J., Le Moine O., Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006 43 5 989 1000 2-s2.0-33646539166 10.1002/hep.21138 (Pubitemid 43724624)
57. Hritz I., Mandrekar P., Velayudham A., Catalano D., Dolganiuc A., Kodys K., Kurt-Jones E., Szabo G., The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 2008 48 4 1224 1231 2-s2.0-54449092214 10.1002/hep.22470
58. Seki E., Brenner D. A., Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008 48 1 322 335 2-s2.0-47149105036 10.1002/hep.22306 (Pubitemid 351975556)
59. Isogawa M., Robek M. D., Furuichi Y., Chisari F. V., Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. Journal of Virology 2005 79 11 7269 7272 2-s2.0-18744399291 10.1128/JVI.79.11.7269-7272.2005 (Pubitemid 40677357)
60. Medzhitov R., Preston-Hurlburt P., Janeway C. A. Jr., A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 1997 388 6640 394 397 2-s2.0-0030831210 10.1038/41131 (Pubitemid 27334820)
61. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S., Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003 301 5633 640 643 2-s2.0-0043176281 10.1126/science.1087262 (Pubitemid 36927946)
62. Szabo G., Petrasek J., Bala S., Innate immunity and alcoholic liver disease. Digestive Diseases 2012 30 S55 S60
63. Szabo G., Mandrekar P., Petrasek J., Catalano D., The unfolding web of innate immune dysregulation in alcoholic liver injury. Alcoholism 2011 35 5 782 786 2-s2.0-79955471005 10.1111/j.1530-0277.2010.01398.x
64. Yin M., Bradford B. U., Wheeler M. D., Uesugi T., Froh M., Goyert S. M., Thurman R. G., Reduced early alcohol-induced liver injury in CD14-deficient mice. Journal of Immunology 2001 166 7 4737 4742 2-s2.0-0035313376 (Pubitemid 32233762)
65. Paik Y.-H., Schwabe R. F., Bataller R., Russo M. P., Jobin C., Brenner D. A., Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003 37 5 1043 1055 2-s2.0-0038185316 10.1053/jhep.2003.50182 (Pubitemid 36538681)
66. Nagy L. E., Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Experimental Biology and Medicine 2003 228 8 882 890 2-s2.0-0141625009 (Pubitemid 37163241)
67. Fujimoto M., Uemura M., Nakatani Y., Tsujita S., Hoppo K., Tamagawa T., Kitano H., Kikukawa M., Ann T., Ishii Y., Kojima H., Sakurai S., Tanaka R., Namisaki T., Noguchi R., Higashino T., Kikuchi E., Nishimura K., Takaya A., Fukui H., Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcoholism 2000 24 4 S48 S54 2-s2.0-0034014905
68. Fukui H., Brauner B., Bode J. C., Bode C., Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. Journal of Hepatology 1991 12 2 162 169 2-s2.0-0026078067
69. Gustot T., Lemmers A., Moreno C., Nagy N., Quertinmont E., Nicaise C., Franchimont D., Louis H., Devière J., Le Moine O., Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006 43 5 989 1000 2-s2.0-33646539166 10.1002/hep.21138 (Pubitemid 43724624)
70. Mandrekar P., Catalano D., White B., Szabo G., Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. Alcoholism 2006 30 1 135 139 2-s2.0-33644781712 10.1111/j.1530-0277.2006.00012.x (Pubitemid 43341406)
71. Byun J. S., Suh Y. G., Yi H. S., Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. Journal of Hepatology 2013 58 342 349
72. Samanta M., Iwakiri D., Takada K., Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008 27 30 4150 4160 2-s2.0-47049129929 10.1038/onc.2008.75 (Pubitemid 351969916)
73. Meylan E., Tschopp J., Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Molecular Cell 2006 22 5 561 569 2-s2.0-33744539798 10.1016/j.molcel.2006.05.012 (Pubitemid 43817607)
74. Zhao X.-J., Dong Q., Bindas J., Piganelli J. D., Magill A., Reiser J., Kolls J. K., TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. Journal of Immunology 2008 181 5 3049 3056 2-s2.0-51549118941
75. Dominguez M., Miquel R., Colmenero J., Moreno M., García- Pagán J.-C., Bosch J., Arroyo V., Ginès P., Caballería J., Bataller R., Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009 136 5 1639 1650 2-s2.0-65249087414 10.1053/j.gastro.2009.01.056
76. Colmenero J., Bataller R., Sancho-Bru P., Bellot P., Miquel R., Moreno M., Jares P., Bosch J., Arroyo V., Caballería J., Ginès P., Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007 132 2 687 697 2-s2.0-33847039276 10.1053/j.gastro.2006.12.036 (Pubitemid 46274670)
77. Simpson K. J., Henderson N. C., Bone-Larson C. L., Lukacs N. W., Hogaboam C. M., Kunkel S. L., Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clinical Science 2003 104 1 47 63 2-s2.0-0037284514 10.1042/CS20020137 (Pubitemid 36249923)
78. Jiang Y., Beller D. I., Frendl G., Graves D. T., Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. Journal of Immunology 1992 148 8 2423 2428 2-s2.0-0026547872
79. Fisher N. C., Neil D. A. H., Williams A., Adams D. H., Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 α in alcoholic liver disease. Gut 1999 45 3 416 420 2-s2.0-0032795476 (Pubitemid 29400720)
80. Lu B., Rutledge B. J., Gu L., Fiorillo J., Lukacs N. W., Kunkel S. L., North R., Gerard C., Rollins B. J., Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. The Journal of Experimental Medicine 1998 187 4 601 608 2-s2.0-0032536531 10.1084/jem.187.4.601 (Pubitemid 28093362)
81. Mandrekar P., Ambade A., Lim A., Szabo G., Catalano D., An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 2011 54 6 2185 2197 2-s2.0-82455167937 10.1002/hep.24599
82. Schroder K., Tschopp J., The inflammasomes. Cell 2010 140 6 821 832 2-s2.0-77950362382 10.1016/j.cell.2010.01.040
83. Cayrol C., Girard J.-P., The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences of the United States of America 2009 106 22 9021 9026 2-s2.0-67049158193 10.1073/pnas.0812690106
84. Martinon F., Mayor A., Tschopp J., The inflammasomes: guardians of the body. Annual Review of Immunology 2009 27 229 265 2-s2.0-66749174867 10.1146/annurev.immunol.021908.132715
85. Valles S. L., Blanco A. M., Azorin I., Guasch R., Pascual M., Gomez-Lechon M. J., Renau-Piqueras J., Guerri C., Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes. Alcoholism 2003 27 12 1979 1986 2-s2.0-0347625579 10.1097/01.ALC.0000099261.87880.21 (Pubitemid 38005067)
86. Lech M., Avila-Ferrufino A., Skuginna V., Susanti H. E., Anders H.-J., Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. International Immunology 2010 22 9 717 728 2-s2.0-77956103055 10.1093/intimm/dxq058
87. Iimuro Y., Bradford B. U., Yamashina S., Rusyn I., Nakagami M., Enomoto N., Kono H., Frey W., Forman D., Brenner D., Thurman R. G., The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology 2000 31 2 391 398 2-s2.0-0011024223 (Pubitemid 30078604)
88. Wu D., Cederbaum A. I., Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1. Alcoholism 1999 23 1 67 76 2-s2.0-0032904051 (Pubitemid 29068468)
89. Wheeler M. D., Endotoxin and kupffer cell activation in alcoholic liver disease. Alcohol Research and Health 2003 27 4 300 306 2-s2.0-16544368662 (Pubitemid 40685569)
90. Albano E., Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Molecular Aspects of Medicine 2008 29 1-2 9 16 2-s2.0-39749090649 10.1016/j.mam.2007.09.004 (Pubitemid 351312214)
91. Keshavarzian A., Farhadi A., Forsyth C. B., Rangan J., Jakate S., Shaikh M., Banan A., Fields J. Z., Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. Journal of Hepatology 2009 50 3 538 547 2-s2.0-59549106331 10.1016/j.jhep.2008.10.028
92. Keshavarzian A., Holmes E. W., Patel M., Iber F., Fields J. Z., Pethkar S., Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol- induced liver damage. American Journal of Gastroenterology 1999 94 1 200 207 2-s2.0-0032920540 10.1111/j.1572-0241.1999.00797.x (Pubitemid 29063469)
93. Bala S., Marcos M., Kodys K., Csak T., Catalano D., Mandrekar P., Szabo G., Up-regulation of microRNA-155 in macrophages contributes to increased Tumor Necrosis Factor α (TNF α) production via increased mRNA half-life in alcoholic liver disease. Journal of Biological Chemistry 2011 286 2 1436 1444 2-s2.0-78651399501 10.1074/jbc.M110.145870
94. Sheth P., Seth A., Atkinson K. J., Gheyi T., Kale G., Giorgianni F., Desiderio D. M., Li C., Naren A., Rao R., Acetaldehyde dissociates the PTP1B-E-cadherin- β -catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. The Biochemical Journal 2007 402 2 291 300 2-s2.0-33847743407 10.1042/BJ20060665 (Pubitemid 46383426)
95. Yumuk Z., Ozdemirci S., Faruk Erden B., Dundar V., The effect of long-term ethanol feeding on Brucella melitensis infection of rats. Alcohol and Alcoholism 2001 36 4 314 317 2-s2.0-0034940506 (Pubitemid 32655228)
96. Kavanaugh M. J., Clark C., Goto M., Kovacs E. J., Gamelli R. L., Sayeed M. M., Choudhry M. A., Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function. Burns 2005 31 3 290 296 2-s2.0-14944370045 10.1016/j.burns.2004.09.021 (Pubitemid 40363935)
97. Wheeler M. D., Kono H., Yin M., Nakagami M., Uesugi T., Arteel G. E., Gäbele E., Rusyn I., Yamashina S., Froh M., Adachi Y., Iimuro Y., Bradford B. U., Smutney O. M., Connor H. D., Mason R. P., Goyert S. M., Peters J. M., Gonzalez F. J., Samulski R. J., Thurman R. G., The role of kupffer cell oxidant production in early ethanol-induced liver disease. Free Radical Biology and Medicine 2001 31 12 1544 1549 2-s2.0-0035893937 10.1016/S0891-5849(01)00748-1 (Pubitemid 34026339)
98. Thakur V., McMullen M. R., Pritchard M. T., Nagy L. E., Regulation of macrophage activation in alcoholic liver disease. Journal of Gastroenterology and Hepatology 2007 22 1 S53 S56 2-s2.0-34249809161 10.1111/j.1440-1746.2006. 04650.x (Pubitemid 46848991)
99. Rao R., Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 2009 50 2 638 644 2-s2.0-68949178506 10.1002/hep.23009
100. Yan A. W., Fouts D. E., Brandl J., Stärkel P., Torralba M., Schott E., Tsukamoto H., Nelson K. E., Brenner D. A., Schnabl B., Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011 53 1 96 105 2-s2.0-78751537350 10.1002/hep.24018
101. Keshavarzian A., Fields J. Z., Vaeth J., Holmes E. W., The differing effects of acute and chronic alcohol on gastric and intestinal permeability. American Journal of Gastroenterology 1994 89 12 2205 2211 2-s2.0-0027997978 (Pubitemid 24363671)
102. Choudhry M. A., Fazal N., Goto M., Gamelli R. L., Sayeed M. M., Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2002 282 6 G937 G947 2-s2.0-0036087233 (Pubitemid 34651599)
103. Keshavarzian A., Choudhary S., Holmes E. W., Yong S., Banan A., Jakate S., Fields J. Z., Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. Journal of Pharmacology and Experimental Therapeutics 2001 299 2 442 448 2-s2.0-0034757037 (Pubitemid 32979654)
104. Szabo G., Bala S., Alcoholic liver disease and the gut-liver axis. World Journal of Gastroenterology 2010 16 11 1321 1329 2-s2.0-77950825001 10.3748/wjg.v16.i11.1321
105. Adachi Y., Moore L. E., Bradford B. U., Gao W., Thurman R. G., Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995 108 1 218 224 2-s2.0-0028796860 10.1016/0016-5085(95)90027-6
106. Gao B., Bataller R., Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011 141 5 1572 1585 2-s2.0-80054872790 10.1053/j.gastro.2011.09.002
107. O'Shea R. S., Dasarathy S., McCullough A. J., Alcoholic liver disease. Hepatology 2010 51 307 328
108. Lieber C. S., DeCarli L. M., Alcoholic liver injury: experimental models in rats and baboons. Advances in Experimental Medicine and Biology 1975 59 379 393 2-s2.0-0016600027
109. Tsukamoto H., French S. W., Benson N., Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 1985 5 2 224 232 2-s2.0-0021923933 (Pubitemid 15115999)
110. Tsukamoto H., Towner S. J., Ciofalo L. M., French S. W., Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 1986 6 5 814 822 2-s2.0-0022510347 (Pubitemid 16006732)
111. French S. W., Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. Journal of Biomedical Science 2001 8 1 20 27 2-s2.0-0035138847 10.1159/000054009 (Pubitemid 32098482)
112. Nanji A. A., Khettry U., Sadrzadeh S. M. H., Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proceedings of the Society for Experimental Biology and Medicine 1994 205 3 243 247 2-s2.0-0028220726 (Pubitemid 24108319)
113. Tsujimoto T., Kawaratani H., Yoshiji H., Uemura M., Fukui H., Recent developments in the treatment of alcoholic chronic pancreatitis. Current Drug Abuse Reviews 2008 1 2 197 202 2-s2.0-69249225655